İDİLMAN, R. Et Al. 2017. Efficacy of ledipasvir and sofosbuvir with/without Ribavirin for treatment of chronic hepatitis C patients with advanced liver disease Results of a multicenter Turkish Early access program. AASLD VIRAL HEPATITIS .

İDİLMAN, R., DEMİR, M., ALADAĞ, M., KAYMAKOĞLU, S., CİHAN, E., ÇAVUŞ, B., ... ILLİAZ, R.(2017). Efficacy of ledipasvir and sofosbuvir with/without Ribavirin for treatment of chronic hepatitis C patients with advanced liver disease Results of a multicenter Turkish Early access program . AASLD VIRAL HEPATITIS

İDİLMAN, RAMAZAN Et Al. "Efficacy of ledipasvir and sofosbuvir with/without Ribavirin for treatment of chronic hepatitis C patients with advanced liver disease Results of a multicenter Turkish Early access program," AASLD VIRAL HEPATITIS, 2017

İDİLMAN, RAMAZAN Et Al. "Efficacy of ledipasvir and sofosbuvir with/without Ribavirin for treatment of chronic hepatitis C patients with advanced liver disease Results of a multicenter Turkish Early access program." AASLD VIRAL HEPATITIS , 2017

İDİLMAN, R. Et Al. (2017) . "Efficacy of ledipasvir and sofosbuvir with/without Ribavirin for treatment of chronic hepatitis C patients with advanced liver disease Results of a multicenter Turkish Early access program." AASLD VIRAL HEPATITIS .

@conferencepaper{conferencepaper, author={RAMAZAN İDİLMAN Et Al. }, title={Efficacy of ledipasvir and sofosbuvir with/without Ribavirin for treatment of chronic hepatitis C patients with advanced liver disease Results of a multicenter Turkish Early access program}, congress name={AASLD VIRAL HEPATITIS}, city={}, country={}, year={2017}}